María Carolina Isaza López

Dr. María Carolina Isaza López

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Revista chilena de pediatría
Verified
Journal Article
Closed access
PDF file
MLMaría Carolina Isaza López
María Carolina Isaza López
LRLuisa Fernanda Rojas Rosas
Luisa Fernanda Rojas Rosas
LEL. Echavarría-Ospina
L. Echavarría-Ospina
LSLm. Serna-Higuita
Lm. Serna-Higuita
Sickle cell nephropathy (SCN) is a poorly studied complication of pediatric patients. It appears in different forms, including glomerulopathy, and tubulopathies. Objective: To describe acute and chronic renal complications in patients with sickle cell anemia (SCA). Patients and Method: Retrospective study. Pediatric patients with confirmed diagnosis of sickle cell disease were included who had a nephro-urology study. Hemoglobin electrophoresis pattern, presence and type of renal involvement, and presence of cardiac involvement were recorded. Bivariate analysis was performed to compare patients with and without SCN. Results: 79 patients were included, 59.5% of them were men, and the most frequent electrophoresis pattern was Hb-SS (60.9%). The SCN occurred in 70% of patients with an average age of 114 months (RIQ 65-157). The most frequently observed alterations were glomerular hyperfiltration, microalbuminuria, acute kidney injury, arterial hypertension, and hyposthenuria. In the bivariate analysis, an abnormal echocardiogram result was presented more frequently in patients with SCN (84.8% vs. 54.3% p = 0.01), as well as more frequent use of nephrotoxic drugs (74.5% vs. 54.2% p = 0.07). Conclusions: Our findings suggest that sickle cell nephropathy may occur at an early age, where glomerular hyperfiltration is very common. Cardiopulmonary complications in patients with SCA may be related to the presence of SCN.

24 December 2024 in BMJ Paediatrics Open
Verified
Journal Article
Open access
PDF file
MCMaria Alejandra Calvo-Herrera
Maria Alejandra Calvo-Herrera
ASAngelica Maria Serna-Campuzano
Angelica Maria Serna-Campuzano
MLMaría Carolina Isaza López
María Carolina Isaza López
EAEsteban Villegas Arbeláez
Esteban Villegas Arbeláez
LRLuisa Fernanda Rojas-Rosas
Luisa Fernanda Rojas-Rosas
COCarolina Lucia Ochoa-García
Carolina Lucia Ochoa-García
Background: Post-transplantation diabetes mellitus and carbohydrate intolerance (PTDM/iCHO) are complications following solid organ transplantation, which significantly increases the risk of graft loss and mortality. However, data concerning long-term outcomes in paediatric kidney transplant recipients with PTDM/iCHO are scarce. This study aimed to evaluate the risk of graft loss in paediatric kidney transplant recipients with PTDM or iCHO compared with non-PTDM/iCHO.Methods: The study cohort included patients aged <18 who underwent a kidney transplant in a transplant centre from 2005 to 2022. The primary outcome was graft survival loss; secondary outcomes were acute rejection, renal function and mortality. Cumulative incidence of graft loss and acute rejection was estimated, considering death a competing risk. Fine and Gray’s proportional subdistribution hazard model was used to analyse the effect of PTDM/iCHO status on the event.Results: Seventy-six paediatric kidney transplant recipients were included. The incidence of PTDM and iCHO was 6.6% and 9.2%, respectively. Patients with PTDM/iCHO had a significantly higher cumulative graft loss incidence than those without (34.4% vs 13.9% at 36 months, p<0.008). Multivariable analysis revealed a threefold increased risk of graft loss in patients with PTDM/iCHO (HRadjusted3.33, 95% CI 1.19 to 9.30, p=0.022). PTDM/iCHO was associated with a higher incidence of acute rejection (33.3% vs 14.5% at 1 year, p=0.025). Patients with PTDM/iCHO also exhibited significantly worse eGFR at all time points compared with patients without PTDM/iCHO (p=0.036)Conclusion: Patients with PTDM and iCHO had a higher risk of graft loss and lower renal function in paediatric kidney transplant recipients. This justifies close monitoring of metabolic complications in these patients.

8 November 2023 in Transplantation Direct
Verified
Journal Article
Open access
Lina Maria Serna HiguitaLina Maria Serna Higuita
Lina Maria Serna Higuita
MLMaría Carolina Isaza López
María Carolina Isaza López
GHGilma Norela Hernández-Herrera
Gilma Norela Hernández-Herrera
ASAngelica Maria Serna-Campuzano
Angelica Maria Serna-Campuzano
JNJohn Fredy Nieto-Rios
John Fredy Nieto-Rios
MGMartina Guthoff
Martina Guthoff
Background. Posttransplantation diabetes mellitus (PTDM) is a serious complication of solid organ transplantation. It is associated with major adverse cardiovascular events, which are a leading cause of morbidity and mortality in transplant patients. This study aimed to develop and validate a score to predict the risk of PTDM in kidney transplant recipients. Methods. A single-center retrospective cohort study was conducted in a tertiary care hospital in Medellín, Colombia, between 2005 and 2019. Data from 727 kidney transplant recipients were used to develop a risk prediction model. Significant predictors with competing risks were identified using time-dependent Cox proportional hazard regression models. To build the prediction model, the score for each variable was weighted using calculated regression coefficients. External validation was performed using independent data, including 198 kidney transplant recipients from Tübingen, Germany. Results. Among the 727 kidney transplant recipients, 122 developed PTDM. The predictive model was based on 5 predictors (age, gender, body mass index, tacrolimus therapy, and transient posttransplantation hyperglycemia) and exhibited good predictive performance (C-index: 0.7 [95% confidence interval, 0.65-0.76]). The risk score, which included 33 patients with PTDM, was used as a validation data set. The results showed good discrimination (C-index: 0.72 [95% confidence interval, 0.62-0.84]). The Brier score and calibration plot demonstrated an acceptable fit capability in external validation. Conclusions. We proposed and validated a prognostic model to predict the risk of PTDM, which performed well in discrimination and calibration, and is a simple score for use and implementation by means of a nomogram for routine clinical application. Export

1 January 2024 in Revista Facultad Nacional de Salud Pública
Verified
Journal Article
Open access
PDF file
MLMaría Carolina Isaza López
María Carolina Isaza López
MDMónica D’aMato-Gutiérrez
Mónica D’aMato-Gutiérrez
JEJenifer López Echeverry
Jenifer López Echeverry
SZSofía López Zapata
Sofía López Zapata
CCCielo Carolina Casas Cruz
Cielo Carolina Casas Cruz
YPYudy Alexandra Aguilar Pérez
Yudy Alexandra Aguilar Pérez
Objetivo: Comparar las características maternas y los desenlaces neonatales durante la emergencia sanitaria por la covid-19 contra el mismo periodo epidemiológico del año previo a la pandemia. Metodología: Estudio de corte en dos momentos del tiempo, de 970 binomios materno-neonatales durante enero-diciembre del 2020 (grupo pandemia) y el mismo período del año 2019 (grupo prepandemia), en un hospital de tercer nivel de Medellín, Colombia. Se obtuvo la información de historias clínicas para las variables de interés; luego, se comparó su frecuencia en ambos grupos, calculando razones de prevalencia y ji al cuadrado. Resultados: Se incluyeron 483 binomios en prepandemia y 487 en pandemia. En esta última, hubo menor cobertura de vacunación neonatal (9,7 vs. 4,6 %; p < 0,001; RP:1,49; IC 95 %: 1,26-1,76) y prevalencia de malformaciones congénitas (8,2 vs. 14,2 %; p = 0,002; RP: 0,73; IC 95 %: 0,57-0,94). No hubo diferencias frente a parto prematuro, mortalidad, hospitalización ni rehospitalización neonatal. En pandemia fue menor el control prenatal adecuado (19,1 vs. 28,6 %; p = 0,001; RP: 1,41; IC 95 %: 1,19-1,67) y comorbilidades detectadas en el parto (6,4 vs. 10,8 %; p = 0,014; RP: 0,69; IC 95 %: 0,52-0,93), y mayor frecuencia de obesidad (6,6 vs. 3,5 %; p = 0,03; rp: 1,42; IC 95 %: 1,13-1,79). Conclusiones: La pandemia por la Covid-19 impactó en la atención del binomio materno-neonatal, en especial con la disminución en la cobertura de la vacunación, la reducción en la detección de comorbilidades maternas y malformaciones congénitas, y en la realización adecuada de los controles prenatales, por lo que es importante fortalecer los programas de atención primaria y focalizar las estrategias en determinantes que modifiquen los desenlaces neonatales.

26 March 2025 in Andes Pediatrica
Verified
Journal Article
Open access
PDF file
MDManuela Rendón Díez
Manuela Rendón Díez
LELuz María Giraldo Echeverri
Luz María Giraldo Echeverri
MBMaría Paulina Betancur Betancur
María Paulina Betancur Betancur
MCMariana Barona Cabrera
Mariana Barona Cabrera
MDMónica D’aMato-Gutiérrez
Mónica D’aMato-Gutiérrez
MLMaría Carolina Isaza López
María Carolina Isaza López
Las cardiopatías congénitas críticas cianóticas (CCCC) son malformaciones graves que se manifiestan por colapso cardiocirculatorio durante el primer mes de vida, de alta mortalidad sin un tratamiento oportuno.Objetivo: Evaluar el rendimiento del protocolo de la Academia Americana de Pediatría (AAP) del uso de oximetría de pulso para la detección temprana de cardiopatías congénitas críticas en neonatos.Pacientes y Método: Estudio prospectivo de pruebas diagnósticas en neonatos mayores de 34 semanas y de 2000 gramos de peso al nacer entre 6 a 48 horas de nacido, entre agosto 2021 y enero 2022. Las variables clínicas se recolectaron de la revisión de historias clínicas. Se excluyeron aquellos con antecedente prenatal de CCCC detectado por ecografía prenatal. De acuerdo con el protocolo de la AAP, cualquier valor de saturación menor de 90%, se consideró un tamizaje positivo. El resultado de la oximetría se evaluó frente a un estándar de referencia compuesto por la ecocardiografía o seguimiento clínico.Resultados: Se incluyeron 609 neonatos, se realizó la prueba de oximetría de pulso con una mediana de 15,4 horas de vida. El 6,9% presentó un tamizaje positivo y se les realizó ecocardiografía. El seguimiento ambulatorio se realizó a 520 con un promedio de 96 días de vida. No se detectó ninguno con cardiopatía congénita crítica. El tamizaje detectó cardiopatías congénitas no críticas con una sensibilidad de 70,7% (IC 95% 55,6 - 85,9) y especificidad de 97,6% (IC 95% 96,1 - 99,0).Conclusiones: La mayoría de los tamizajes realizados tempranamente fueron verdaderos negativos durante el seguimiento ambulatorio. Un tamizaje positivo permitió alertar sobre cardiopatías congénitas no críticas detectadas por ecocardiografía o sobre hipoxemia de causa no cardíaca.

Verified
Journal Article
Open access
PDF file
LRLuisa Fernanda Rojas Rosas
Luisa Fernanda Rojas Rosas
NONatalia Osorio
Natalia Osorio
MNMelissa Navarro
Melissa Navarro
MRMiguel Ángel Restrepo
Miguel Ángel Restrepo
MLMaría Carolina Isaza López
María Carolina Isaza López
Lina Maria Serna HiguitaLina Maria Serna Higuita
Lina Maria Serna Higuita
Introduction: Steroid-resistant nephrotic syndrome (SRNS) represents a severe and challenging form of pediatric nephrotic syndrome and is associated with a high risk of progression to end-stage kidney disease. Calcineurin inhibitors (CNIs) are the standard second-line therapy; however, their use is limited by frequent relapses and long-term nephrotoxicity. Mycophenolate mofetil (MMF) offers a more favorable safety profile and a complementary mechanism of action; however, the clinical utility of combining MMF with CNIs remains largely under-explored in this population. Case Presentation: We describe a series of nine pediatric patients with steroid-resistant or steroid-dependent nephrotic syndrome who were refractory to cyclosporine monotherapy. These patients were treated with a combination regimen of cyclosporine (4–5 mg/kg/day; target trough levels of 75–150 ng/mL) and MMF (600 mg/m2/day). This therapeutic approach was associated with a reduction in corticosteroid dosage and a decrease in the annual number of relapses in most patients. Conclusions: In this small case series of pediatric patients with corticosteroid-dependent or steroid-resistant nephrotic syndrome refractory to cyclosporine monotherapy, the addition of mycophenolate mofetil was associated with a reduction in relapse frequency and corticosteroid requirements. Despite the limited sample size, these findings suggest that combination therapy may be a therapeutic option in difficult-to-treat pediatric nephrotic syndrome and warrant further evaluation in controlled studies.